Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus...

Area of Science:

• Cardiovascular Research
• Medical Device Trials
• Clinical Endpoints

Background:

• The 2007 Academic Research Consortium (ARC) endpoint definitions required updating due to advancements in interventional cardiology.
• Increasing complexity in patient populations and lesion types necessitates refined trial endpoints.
• Novel devices, like bioresorbable vascular scaffolds, demand updated evaluation criteria.

Framework:

• The Academic Research Consortium-2 (ARC-2) initiative convened international experts from academia, industry, and regulatory bodies.
• Multiple meetings focused on evolving device technology, clinical trial methodologies, and regulatory landscapes.
• Consensus was reached on revised clinical and angiographic endpoint definitions for coronary device trials.

Implementation:

• The ARC-2 framework provides updated definitions for clinical and angiographic endpoints.
• Recommendations for integrating patient-reported outcomes into trial designs are included.
• The revised definitions are endorsed by key stakeholders for widespread adoption in research.

Implications:

• Standardized endpoints facilitate consistent interpretation and comparison of coronary device trial results.
• Improved evaluation of safety and effectiveness for both traditional and novel devices.
• Enhanced ability to assess new technologies in complex patient groups, advancing cardiovascular medicine.